Drug
Fludarabine
Fludarabine: highest development phase Phase 2, developed by Fate Therapeutics, Jazz Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Fate Therapeutics, Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fludarabine NCT02718755 | Phase 2 | Hematologic Malignancy |
| Fludarabine NCT00890500 | Phase 1 | Hematologic Malignancies |
Latest
No recent events.
Follow Fludarabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.